Glucose Metabolism Gene Polymorphisms and Clinical Outcome in Pancreatic Cancer

Overview

Journal Cancer

Publisher Wiley

Specialty Oncology

Date 2010 Sep 17

PMID 20845477

Citations 20

Authors

Xiaoqun Dong

Hongwei Tang

Kenneth R Hess

James L Abbruzzese

Donghui Li

Affiliations

Soon will be listed here.

Abstract

Background: Altered glucose metabolism is the most common metabolic hallmark of malignancies. The authors tested the hypothesis that glucose metabolism gene variations affect clinical outcome in pancreatic cancer.

Methods: The authors retrospectively genotyped 26 single nucleotide polymorphisms from 5 glucose metabolism genes in 154 patients with localized disease and validated the findings in 552 patients with different stages of pancreatic adenocarcinoma. Association between genotypes and overall survival (OS) was evaluated using multivariate Cox proportional hazard regression models with adjustment for clinical predictors.

Results: Glucokinase (GCK) IVS1 + 9652C > T and hexokinase 2 (HK2) N692N homozygous variants were significantly associated with reduced OS in the training set of 154 patients (P < .001). These associations were confirmed in the validation set of 552 patients and in the combined dataset of all 706 patients (P ≤ .001). In addition, HK2 R844K variant K allele was associated with a better survival in the validation set and the combined dataset (P ≤ .001). When data were further analyzed by disease stage, glutamine-fructose-6-phosphate transaminase (GFPT1) IVS14-3094T>C, HK2 N692N and R844K in patients with localized disease and GCK IVS1 + 9652C>T in patients with advanced disease were significant independent predictors for OS (P ≤ .001). Haplotype CGG of GPI and GCTATGG of HK2 were associated with better OS, respectively, with P values of .004 and .007.

Conclusions: The authors demonstrated that glucose metabolism gene polymorphisms affect clinical outcome in pancreatic cancer. These observations support a role of abnormal glucose metabolism in pancreatic carcinogenesis.

Citing Articles

Glutamine stabilizes myc via alpha-ketoglutarate and regulates paclitaxel sensitivity.

Bhardwaj V, He J, Jain A Med Oncol. 2022; 39(12):227.

PMID: 36175776 DOI: 10.1007/s12032-022-01834-5.

Tissue metabolomics identified new biomarkers for the diagnosis and prognosis prediction of pancreatic cancer.

Liu C, Qin H, Liu H, Wei T, Wu Z, Shang M Front Oncol. 2022; 12:991051.

PMID: 36119530 PMC: 9479084. DOI: 10.3389/fonc.2022.991051.

Therapeutic resistance in pancreatic ductal adenocarcinoma: Current challenges and future opportunities.

Jain A, Bhardwaj V World J Gastroenterol. 2021; 27(39):6527-6550.

PMID: 34754151 PMC: 8554400. DOI: 10.3748/wjg.v27.i39.6527.

Genetic Signatures of Glucose Homeostasis: Synergistic Interplay With Long-Term Exposure to Cigarette Smoking in Development of Primary Colorectal Cancer Among African American Women.

Jung S Clin Transl Gastroenterol. 2021; 12(10):e00412.

PMID: 34608882 PMC: 8500576. DOI: 10.14309/ctg.0000000000000412.

Glucose Metabolism in Pancreatic Cancer.

Yan L, Raj P, Yao W, Ying H Cancers (Basel). 2019; 11(10).

PMID: 31569510 PMC: 6826406. DOI: 10.3390/cancers11101460.

References

Natsuizaka M, Ozasa M, Darmanin S, Miyamoto M, Kondo S, Kamada S . Synergistic up-regulation of Hexokinase-2, glucose transporters and angiogenic factors in pancreatic cancer cells by glucose deprivation and hypoxia. Exp Cell Res. 2007; 313(15):3337-48. DOI: 10.1016/j.yexcr.2007.06.013. View

Pounds S, Cheng C . Improving false discovery rate estimation. Bioinformatics. 2004; 20(11):1737-45. DOI: 10.1093/bioinformatics/bth160. View

Kurtoglu M, Maher J, Lampidis T . Differential toxic mechanisms of 2-deoxy-D-glucose versus 2-fluorodeoxy-D-glucose in hypoxic and normoxic tumor cells. Antioxid Redox Signal. 2007; 9(9):1383-90. DOI: 10.1089/ars.2007.1714. View

Sperti C, Pasquali C, Chierichetti F, Ferronato A, Decet G, Pedrazzoli S . 18-Fluorodeoxyglucose positron emission tomography in predicting survival of patients with pancreatic carcinoma. J Gastrointest Surg. 2003; 7(8):953-9. DOI: 10.1016/j.gassur.2003.09.002. View

Marshall S . Role of insulin, adipocyte hormones, and nutrient-sensing pathways in regulating fuel metabolism and energy homeostasis: a nutritional perspective of diabetes, obesity, and cancer. Sci STKE. 2006; 2006(346):re7. DOI: 10.1126/stke.3462006re7. View

Dong X, Javle M, Hess K, Shroff R, Abbruzzese J, Li D . Insulin-like growth factor axis gene polymorphisms and clinical outcomes in pancreatic cancer. Gastroenterology. 2010; 139(2):464-73, 473.e1-3. PMC: 2910789. DOI: 10.1053/j.gastro.2010.04.042. View

Goldstein M, Mascitelli L, Pezzetta F . Obesity and survival among patients with pancreatic cancer. JAMA. 2009; 302(16):1752. DOI: 10.1001/jama.2009.1510. View

Palmieri D, Fitzgerald D, Shreeve S, Hua E, Bronder J, Weil R . Analyses of resected human brain metastases of breast cancer reveal the association between up-regulation of hexokinase 2 and poor prognosis. Mol Cancer Res. 2009; 7(9):1438-45. PMC: 2746883. DOI: 10.1158/1541-7786.MCR-09-0234. View

Vousden K, Ryan K . p53 and metabolism. Nat Rev Cancer. 2009; 9(10):691-700. DOI: 10.1038/nrc2715. View

10.

Cao X, Bloomston M, Zhang T, Frankel W, Jia G, Wang B . Synergistic antipancreatic tumor effect by simultaneously targeting hypoxic cancer cells with HSP90 inhibitor and glycolysis inhibitor. Clin Cancer Res. 2008; 14(6):1831-9. DOI: 10.1158/1078-0432.CCR-07-1607. View

11.

Warburg O . On the origin of cancer cells. Science. 1956; 123(3191):309-14. DOI: 10.1126/science.123.3191.309. View

12.

Green H, FRASER I, Ranney D . Male and female differences in enzyme activities of energy metabolism in vastus lateralis muscle. J Neurol Sci. 1984; 65(3):323-31. DOI: 10.1016/0022-510x(84)90095-9. View

13.

Gambhir S . Molecular imaging of cancer with positron emission tomography. Nat Rev Cancer. 2002; 2(9):683-93. DOI: 10.1038/nrc882. View

14.

Sethi J, Vidal-Puig A . Wnt signalling at the crossroads of nutritional regulation. Biochem J. 2008; 416(2):e11-3. PMC: 4303997. DOI: 10.1042/BJ20082074. View

15.

Hammerman P, Fox C, Thompson C . Beginnings of a signal-transduction pathway for bioenergetic control of cell survival. Trends Biochem Sci. 2004; 29(11):586-92. DOI: 10.1016/j.tibs.2004.09.008. View

16.

Dong X, Jiao L, Li Y, Evans D, Wang H, Hess K . Significant associations of mismatch repair gene polymorphisms with clinical outcome of pancreatic cancer. J Clin Oncol. 2009; 27(10):1592-9. PMC: 2668967. DOI: 10.1200/JCO.2008.20.1111. View

17.

Matschinsky F . Glucokinase as glucose sensor and metabolic signal generator in pancreatic beta-cells and hepatocytes. Diabetes. 1990; 39(6):647-52. DOI: 10.2337/diab.39.6.647. View

18.

Gatenby R, Gillies R . Why do cancers have high aerobic glycolysis?. Nat Rev Cancer. 2004; 4(11):891-9. DOI: 10.1038/nrc1478. View

19.

Hulleman E, Kazemier K, Holleman A, VanderWeele D, Rudin C, Broekhuis M . Inhibition of glycolysis modulates prednisolone resistance in acute lymphoblastic leukemia cells. Blood. 2008; 113(9):2014-21. PMC: 4081395. DOI: 10.1182/blood-2008-05-157842. View

20.

Jemal A, Siegel R, Ward E, Hao Y, Xu J, Thun M . Cancer statistics, 2009. CA Cancer J Clin. 2009; 59(4):225-49. DOI: 10.3322/caac.20006. View